Long-Term Tolerability and Safety of HYQVIA/HyQvia in CIDP

NCT02955355 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

85

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Interventions

BIOLOGICAL: HYQVIA

Sponsor

Baxalta now part of Shire

Collaborators

[object Object]